Q2 FY26-27 profit rebounds as revenue and operating earnings improve
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syschem India returned to profit in Q2 FY26-27. Revenue rose 3% to Rs 12,979 lakh from Rs 12,599 lakh in Q1 and was above Rs 11,793 lakh a year earlier. EBITDA rose to Rs 466 lakh from Rs 59 lakh, profit before tax reached Rs 212.94 lakh versus a Rs 145 lakh loss, and net profit was about Rs 190 lakh.
Positive for shareholders as earnings recovered, but weak demand, higher input costs and currency volatility may limit how durable the turnaround is.